Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Gut 2005;54:1674-1675; doi:10.1136/gut.2005.072595
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Haddad, S
Right arrow Articles by Riddell, R H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Haddad, S
Right arrow Articles by Riddell, R H
Topic Collections
Right arrowRelated Article

COMMENTARY

Inflammatory bowel disease

The role of eosinophils in inflammatory bowel disease

S Al-Haddad1, R H Riddell2

1 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
2 Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

Correspondence to:
Correspondence to:
Dr S Al-Haddad
Department of Laboratory Medicine, St Michael’s Hospital, 30 Bond St, Cardinal Carter Wing, Room 2-091, Toronto, Ontario, Canada M5B 1W8; Al-addadS@smh.toronto.on.ca

Numbers of activated eosinophils are higher in patients with active and inactive ulcerative colitis (UC) compared with controls, but higher in the quiescent than in the active phase, indicating that eosinophils may play diverse roles in the pathophysiology of inflammatory bowel disease (proinflammatory versus repair)

Keywords: neutrophils; ulcerative colitis; eosinophils; inflammatory bowel disease; inflammatory cells; Crohn’s disease

The first 150 words of the full text of this article appear below.

Eosinophils are proinflammatory leucocytes that constitute a small percentage of circulating blood cells. In the healthy state, most of these cells reside in the gastrointestinal tract within the lamina propria of the stomach and intestine. They differentiate in the bone marrow from progenitor cells under the influence of interleukin (IL)-3, IL-5, and granulocyte-macrophage colony stimulating factor. IL-5 also stimulates their release into the peripheral circulation.1 They then migrate to the gastrointestinal tract in response to eotaxin, a chemokine that is constitutively expressed throughout the gastrointestinal tract. This chemokine binds to the CCR-3 receptor on eosinophils and is required for their homing to the gastrointestinal tract.2,3 However, constitutive expression of eotaxin is not sufficient for tissue eosinophil trafficking because some gastrointestinal segments (such as the tongue and oesophagus) express eotaxin but are normally devoid of eosinophils.1 So this may explain why the help of other cytokines is needed . . . [Full text of this article]


Related Article

Eosinophil granulocytes are activated during the remission phase of ulcerative colitis
M Lampinen, A Rönnblom, K Amin, G Kristjansson, F Rorsman, P Sangfelt, B Säfsten, M Wagner, A Wanders, O Winqvist, and M Carlson
Gut 2005 54: 1714-1720. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology